OraSure Technologies to Present at the UBS Virtual Global Healthcare Conference

Rhea-AI Summary

BETHLEHEM, Pa., May 15, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies (NASDAQ: OSUR) announces that Dr. Stephen S. Tang, President and CEO, will present at the UBS Virtual Global Healthcare Conference on May 20, 2020, at 10:50 AM EST. The conference will be webcast live, and interested investors can access it via the company's website. A replay will be available for seven days post-event. OraSure provides crucial diagnostic tools and services globally, aiding in the detection of medical conditions. For more details, visit www.orasure.com.

BETHLEHEM, Pa., May 15, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Virtual Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on May 20, 2020, at approximately 10:50 AM Eastern Standard Time (7:50 AM Pacific Time).  Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link.  A replay of the webcast will be available on OraSure Technologies’ web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link: https://event.webcasts.com/starthere.jsp?ei=1309729&tp_key=b56dfb64ac

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries DNA Genotek, Diversigen, CoreBiome (now operating under the Diversigen brand) and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contacts:

100%; border-collapse:collapse !important;">

50%; width:50%; min-width:50%;">Roberto Cuca	50%; width:50%; min-width:50%;">Jeanne Mell
Chief Financial Officer	VP Corporate Communications
610-882-1820	484-353-1575
Investorinfo@orasure.com	media@orasure.com
www.orasure.com	www.orasure.com

FAQ

When will Dr. Stephen S. Tang speak at the UBS Virtual Global Healthcare Conference?

Dr. Stephen S. Tang is scheduled to speak on May 20, 2020, at approximately 10:50 AM Eastern Standard Time.

How can I access the live webcast of the OraSure Technologies presentation?

The live webcast can be accessed through OraSure Technologies' website at www.orasure.com.

Is there a replay available for the UBS Virtual Global Healthcare Conference?

Yes, a replay of the webcast will be available on OraSure Technologies' website for seven days after the event.

What does OraSure Technologies specialize in?

OraSure Technologies specializes in point of care diagnostic tests and specimen collection devices, providing solutions for detecting critical medical conditions.

What ticker symbol is associated with OraSure Technologies?

The ticker symbol for OraSure Technologies is OSUR.